Goldrich to Asharq Al-Awsat: No US Withdrawal from Syria

US Deputy Assistant Secretary of State for Near Eastern Affairs Ethan Goldrich during the interview with Asharq Al-Awsat
US Deputy Assistant Secretary of State for Near Eastern Affairs Ethan Goldrich during the interview with Asharq Al-Awsat
TT

Goldrich to Asharq Al-Awsat: No US Withdrawal from Syria

US Deputy Assistant Secretary of State for Near Eastern Affairs Ethan Goldrich during the interview with Asharq Al-Awsat
US Deputy Assistant Secretary of State for Near Eastern Affairs Ethan Goldrich during the interview with Asharq Al-Awsat

Deputy Assistant Secretary of State for Near Eastern Affairs Ethan Goldrich has told Asharq Al-Awsat that the US does not plan to withdraw its forces from Syria.

The US is committed to “the partnership that we have with the local forces that we work with,” he said.

Here is the full text of the interview.

Question: Mr. Goldrich, thank you so much for taking the time to sit with us today. I know you are leaving your post soon. How do you assess the accomplishments and challenges remaining?

Answer: Thank you very much for the chance to talk with you today. I've been in this position for three years, and so at the end of three years, I can see that there's a lot that we accomplished and a lot that we have left to do. But at the beginning of a time I was here, we had just completed a review of our Syria policy, and we saw that we needed to focus on reducing suffering for the people in Syria. We needed to reduce violence. We needed to hold the regime accountable for things that are done and most importantly, from the US perspective, we needed to keep ISIS from reemerging as a threat to our country and to other countries. At the same time, we also realized that there wouldn't be a solution to the crisis until there was a political process under resolution 2254, so in each of these areas, we've seen both progress and challenges, but of course, on ISIS, we have prevented the reemergence of the threat from northeast Syria, and we've helped deal with people that needed to be repatriated out of the prisons, and we dealt with displaced people in al-Hol to reduce the numbers there. We helped provide for stabilization in those parts of Syria.

Question: I want to talk a little bit about the ISIS situation now that the US troops are still there, do you envision a timeline where they will be withdrawn? Because there were some reports in the press that there is a plan from the Biden administration to withdraw.

Answer: Yeah. So right now, our focus is on the mission that we have there to keep ISIS from reemerging. So I know there have been reports, but I want to make clear that we remain committed to the role that we play in that part of Syria, to the partnership that we have with the local forces that we work with, and to the need to prevent that threat from reemerging.

Question: So you can assure people who are saying that you might withdraw, that you are remaining for the time being?

Answer: Yes, and that we remain committed to this mission which needs to continue to be pursued.

Question: You also mentioned the importance of humanitarian aid. The US has been leading on this. Are you satisfied with where you are today on the humanitarian front in Syria?

Answer: We remain committed to the role that we play to provide for humanitarian assistance in Syria. Of the money that was pledged in Brussels, we pledged $593 million just this past spring, and we overall, since the beginning of the conflict, have provided $18 billion both to help the Syrians who are inside of Syria and to help the refugees who are in surrounding countries. And so we remain committed to providing that assistance, and we remain keenly aware that 90% of Syrians are living in poverty right now, and that there's been suffering there. We're doing everything we can to reduce the suffering, but I think where we would really like to be is where there's a larger solution to the whole crisis, so Syrian people someday will be able to provide again for themselves and not need this assistance.

Question: And that's a perfect key to my next question. Solution in Syria. you are aware that the countries in the region are opening up to Assad again, and you also have the EU signaling overture to the Syrian regime and Assad. How do you deal with that?

Answer: For the United States, our policy continues to be that we will not normalize with the regime in Syria until there's been authentic and enduring progress on the goals of resolution 2254, until the human rights of the Syrian people are respected and until they have the civil and human rights that they deserve. We know other countries have engaged with the regime. When those engagements happen, we don't support them, but we remind the countries that are engaged that they should be using their engagements to push forward on the shared international goals under 2254, and that whatever it is that they're doing should be for the sake of improving the situation of the Syrian people.

Question: Let's say that all of the countries decided to talk to Assad, aren’t you worried that the US will be alienated in the process?

Answer: The US will remain true to our own principles and our own policies and our own laws, and the path for the regime in Syria to change its relationship with us is very clear, if they change the behaviors that led to the laws that we have and to the policies that we have, if those behaviors change and the circumstances inside of Syria change, then it's possible to have a different kind of relationship, but that's where it has to start.

Question: My last question to you before you leave, if you have to pick one thing that you need to do in Syria today, what is it that you would like to see happening today?

Answer: So there are a number of things, I think that will always be left and that there are things that we will try to do, to try to make them happen. We want to hold people accountable in Syria for things that have happened. So even today, we observed something called the International Day for victims of enforced disappearances, there are people that are missing, and we're trying to draw attention to the need to account for the missing people. So our step today was to sanction a number of officials who were responsible for enforced disappearances, but we also created something called the independent institution for missing persons, and that helps the families, in the non-political way, get information on what's happened. So I'd like to see some peace for the families of the missing people. I'd like to see the beginning of a political process, there hasn't been a meeting of the constitutional committee in two years, and I think that's because the regime has not been cooperating in political process steps. So we need to change that situation. And I would, of course, like it's important to see the continuation of the things that we were talking about, so keeping ISIS from reemerging and maintaining assistance as necessary in the humanitarian sphere. So all these things, some of them are ongoing, and some of them remain to be achieved. But the Syrian people deserve all aspects of our policy to be fulfilled and for them to be able to return to a normal life.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.